To gain a better understanding of the function of TPX2 and TTK in the context of CRC tumors, we retrieved transcriptomic data from the TCGA COAD cohort (n = 512) and grouped the patients into high vs. low based on median TPX2 or TTK expression. Here, TPX2 is linked to colorectal carcinoma.